These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 29703167

  • 1. Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
    Wang H, Cheng X, Ye J, Xu X, Hong Y, Sui L, You Z, Xie X.
    BMC Cancer; 2018 Apr 27; 18(1):487. PubMed ID: 29703167
    [Abstract] [Full Text] [Related]

  • 2. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
    Coutlée F, Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL.
    J Med Virol; 2011 Jun 27; 83(6):1034-41. PubMed ID: 21503917
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
    Aleksioska-Papestiev I, Chibisheva V, Micevska M, Dimitrov G.
    Med Arch; 2018 Feb 27; 72(1):26-30. PubMed ID: 29416214
    [Abstract] [Full Text] [Related]

  • 4. Human papillomavirus in invasive cervical cancer and cervical intraepithelial neoplasia 2 and 3 in Venezuela: a cross-sectional study.
    Sánchez-Lander J, Cortiñas P, Loureiro CL, Pujol FH, Medina F, Capote-Negrín L, Bianchi G, García-Barriola V, Ruiz-Benni A, Avilán-Rovira J, Acosta H.
    Cancer Epidemiol; 2012 Oct 27; 36(5):e284-7. PubMed ID: 22608058
    [Abstract] [Full Text] [Related]

  • 5. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe.
    Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O'Leary J, Joura EA, Rosenlund M, Colau B, Schledermann D, Kukk K, Damaskou V, Repanti M, Vladareanu R, Kolomiets L, Savicheva A, Shipitsyna E, Ordi J, Molijn A, Quint W, Raillard A, Rosillon D, De Souza SC, Jenkins D, Holl K, HERACLES/SCALE Study Group.
    Int J Cancer; 2013 Feb 15; 132(4):854-67. PubMed ID: 22752992
    [Abstract] [Full Text] [Related]

  • 6. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ, Lissenberg-Witte BI, de Koning MNC, Pinedo HM, Kenter GG, Meijer CJ, Quint WG.
    Sex Transm Infect; 2018 Jun 15; 94(4):263-267. PubMed ID: 29021405
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China.
    Liu X, Zhang S, Ruan Q, Ji Y, Ma L, Zhang Y.
    Int J Gynecol Cancer; 2010 Jan 15; 20(1):147-53. PubMed ID: 20130516
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
    Zhang J, Cheng K, Wang Z.
    Arch Gynecol Obstet; 2020 Dec 15; 302(6):1329-1337. PubMed ID: 32914222
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009-2019.
    Liu Y, Ang Q, Wu H, Xu J, Chen D, Zhao H, Liu H, Guo X, Gu Y, Qiu H.
    Virol J; 2020 Jul 13; 17(1):104. PubMed ID: 32660490
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
    Onuki M, Matsumoto K, Iwata T, Yamamoto K, Aoki Y, Maenohara S, Tsuda N, Kamiura S, Takehara K, Horie K, Tasaka N, Yahata H, Takei Y, Aoki Y, Kato H, Motohara T, Nakamura K, Ishikawa M, Kato T, Yoshida H, Matsumura N, Nakai H, Shigeta S, Takahashi F, Noda K, Yaegashi N, Yoshikawa H.
    Cancer Sci; 2020 Jul 13; 111(7):2546-2557. PubMed ID: 32372453
    [Abstract] [Full Text] [Related]

  • 11. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia.
    Quek SC, Lim BK, Domingo E, Soon R, Park JS, Vu TN, Tay EH, Le QT, Kim YT, Vu BQ, Cao NT, Limson G, Pham VT, Molijn A, Ramakrishnan G, Chen J.
    Int J Gynecol Cancer; 2013 Jan 13; 23(1):148-56. PubMed ID: 23221730
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: data from the ATHENA trial.
    Monsonego J, Cox JT, Behrens C, Sandri M, Franco EL, Yap PS, Huh W.
    Gynecol Oncol; 2015 Apr 13; 137(1):47-54. PubMed ID: 25667973
    [Abstract] [Full Text] [Related]

  • 13. Incidence risk of cervical intraepithelial neoplasia 3 or more severe lesions is a function of human papillomavirus genotypes and severity of cytological and histological abnormalities in adult Japanese women.
    Hosaka M, Fujita H, Hanley SJ, Sasaki T, Shirakawa Y, Abiko M, Kudo M, Kaneuchi M, Watari H, Kikuchi K, Sakuragi N.
    Int J Cancer; 2013 Jan 15; 132(2):327-34. PubMed ID: 22729477
    [Abstract] [Full Text] [Related]

  • 14. Prevalence of Human Papillomavirus Genotypes Among Women With High-Grade Cervical Lesions in Beijing, China.
    Xiao M, Xu Q, Li H, Gao H, Bie Y, Zhang Z.
    Medicine (Baltimore); 2016 Jan 15; 95(3):e2555. PubMed ID: 26817906
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
    Pista A, de Oliveira CF, Lopes C, Cunha MJ, CLEOPATRE Portugal Study Groupa.
    Int J Gynecol Cancer; 2013 Mar 15; 23(3):500-6. PubMed ID: 23392401
    [Abstract] [Full Text] [Related]

  • 16. Attribution of human papillomavirus types to cervical intraepithelial neoplasia and invasive cancers in Southern China.
    Chan PK, Cheung TH, Li WH, Yu MY, Chan MY, Yim SF, Ho WC, Yeung AC, Ho KM, Ng HK.
    Int J Cancer; 2012 Aug 01; 131(3):692-705. PubMed ID: 21976212
    [Abstract] [Full Text] [Related]

  • 17. HPV genotype distribution according to severity of cervical neoplasia.
    Sjoeborg KD, Tropé A, Lie AK, Jonassen CM, Steinbakk M, Hansen M, Jacobsen MB, Cuschieri K, Eskild A.
    Gynecol Oncol; 2010 Jul 01; 118(1):29-34. PubMed ID: 20406711
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D, Zhang L, Xie F, Peng D, Wei J, Jiang L, Zhang S, Qi D.
    BMC Cancer; 2020 Aug 26; 20(1):810. PubMed ID: 32847541
    [Abstract] [Full Text] [Related]

  • 19. HPV-16, HPV-58, and HPV-33 are the most carcinogenic HPV genotypes in Southwestern China and their viral loads are associated with severity of premalignant lesions in the cervix.
    Long W, Yang Z, Li X, Chen M, Liu J, Zhang Y, Sun X.
    Virol J; 2018 May 25; 15(1):94. PubMed ID: 29801461
    [Abstract] [Full Text] [Related]

  • 20. The DNA load of six high-risk human papillomavirus types and its association with cervical lesions.
    Del Río-Ospina L, Soto-De León SC, Camargo M, Moreno-Pérez DA, Sánchez R, Pérez-Prados A, Patarroyo ME, Patarroyo MA.
    BMC Cancer; 2015 Mar 05; 15():100. PubMed ID: 25885207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.